MO
Therapeutic Areas
GRIP Molecular Technologies Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Platform Development | Sexually Transmitted Infections (STIs), Urinary Tract Infections (UTIs), Upper Respiratory Infections (URIs) | Pre-clinical |
| Drug | Indication | Phase |
|---|---|---|
| Platform Development | Sexually Transmitted Infections (STIs), Urinary Tract Infections (UTIs), Upper Respiratory Infections (URIs) | Pre-clinical |